Rat IgG2b-CY5

Cat. No.
0.1 mg  
Price (USD)
Clone KLH/G2b-1-2
Isotype Rat IgG2bκ
Specificity KLH
Format/Conjugate CY5 (Cyanine 5)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Concentration 0.1 mg/mL
Volume 1.0 mL
Storage & Handling 2-8°C; Avoid exposure to light
Please refer to product specific SDS
Applications for relevant formats of this clone include -
Flow Cytometry – Quality tested 1-11,14
ELISA – Quality tested
FLISA – Quality tested
Immunohistochemistry-Frozen Sections – Reported in literature 12
Immunohistochemistry-Paraffin Sections – Reported in literature 14
In vivo Control – Reported in literature 13
Recommended Dilutions Please refer to product specific Technical Bulletin
RRID AB_2794022
  • Human peripheral blood lymphocytes were stained with Rat IgG2b-CY5 (SB Cat No. 0118-15).
  • BALB/c mouse splenocytes were stained with Rat IgG2b-CY5 (SB Cat. No. 0118-15).

Human peripheral blood lymphocytes were stained with Rat IgG2b-CY5 (SB Cat No. 0118-15).

BALB/c mouse splenocytes were stained with Rat IgG2b-CY5 (SB Cat. No. 0118-15).
Related Products (7)
1. Frederiksen PD, Thiel S, Larsen CB, Jensenius JC. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol. 2005;62:462-73. (FC)
2. Yamaji T, Mitsuki M, Teranishi T, Hashimoto Y. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs. Glycobiology. 2005;15:667-76. (FC)
3. Chen L, Arora M, Yarlagadda M, Oriss TB, Krishnamoorthy N, Ray A, et al. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide. J Immunol. 2006;177:2373-83. (FC)
4. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:893-900. (FC)
5. Mausner-Fainberg K, Luboshits G, Mor A, Maysel-Auslender S, Rubinstein A, Keren G, et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis. 2008;197:829-39. (FC)
6. Afek A, Kogan E, Maysel-Auslender S, Mor A, Regev E, Rubinstein A, et al. Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvasc Res. 2009;77:364-9. (FC)
7. Vanden Bush TJ, Buchta CM, Claudio J, Bishop GA. Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes. J Immunol. 2009;183:4833-7. (FC)
8. Lee H, Trott JS, Haque S, McCormick S, Chiorazzi N, Mongini PK. A cyclooxygenase-2/prostaglandin E2 pathway augments activation-induced cytosine deaminase expression within replicating human B cells. J Immunol. 2010;185:5300-14. (FC)
9. Wismar R, Brix S, Lærke HN, Frøkiær H. Comparative analysis of a large panel of non-starch polysaccharides reveals structures with selective regulatory properties in dendritic cells. Mol Nutr Food Res. 2011;55:443-54. (FC)
10. Chu VT, Fröhlich A, Steinhauser G, Scheel T, Roch T, Fillatreau S, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12:151-60. (FC)
11. Koduru S, Wong E, Strowig T, Sundaram R, Zhang L, Strout MP, et al. Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma. Blood. 2012;119:2302-9. (FC)
12. Løvås T, Bruusgaard JC, Øynebråten I, Gundersen K, Bogen B. DNA vaccines: MHC II-targeted vaccine protein produced by transfected muscle fibres induces a local inflammatory cell infiltrate in mice. PLoS One. 2014;9(10):e108069. (IHC-FS)
13. Gong Y, Koh D. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 2010;339:437-48. (In vivo control)
14. Widney DP, Gui D, Popoviciu LM, Said JW, Breen EC, Huang X. Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma. AIDS Research and Treatment. 2010;2010:164586. (FC, IHC-PS)
Cy® is a registered trademark of GE Healthcare